The LRRKtide peptide sequence (RLGRDKYKTLRQIRQ) is derived from human ezrin (amino acids 561-573), moesin (amino acids 539-553) and radixin (amino acids 558-570) and is suitable for use as a substrate for LRRK kinases.
Catalog No. L10-58
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| L10-58 | 1 mg | $83 | |
| L10-58-BULK | BULK | Contact Us |
No overview information available.
Purity:
The purity was determined to be 97.6% by HPLC analysis.
Storage, Stability and Shipping:
Store product at –20oC. For optimal storage, aliquot diluted product into smaller quantities and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
1931.29
RESTRICTION:
Use of this product in assays for LRRK2 inhibitors falls within the scope of the claims of the Medical Research Council’s granted US patent 7947468 and international patent application WO2008122789 and consequently any commercial use of this product in such assays may require a licence from the Medical Research Council. For enquiries about commercial licences to this patent family, please contact Dr Mary Canning at MRC Technology. Email: mary.canning@tech.mrc.ac.uk Telephone: +44(0)20 7391 2801.
Neurobiology
LRRK2 (D1994A), Active, L10-12FG
LRRK2 (G2019S), Active, L10-12GG
LRRK2 (R1441G), Active, L10-12BG
LRRK2 (Y1699C), Active, L10-12DG
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com